About 6.8 million Americans are treated for broken bones each year, and while most heal without intervention, roughly 10 percent of fractures develop complications that can lead to refracture, extended painful recoveries, or permanent disability, according to the University of Rochester. Doctors typically rely on X-rays to monitor healing, but radiation exposure limits how frequently those scans can be used.

Researchers at the University of Rochester are working on a non-invasive alternative that uses near-infrared light instead of radiation, which would allow for more frequent monitoring. The technique, developed by Regine Choe, the Marylou Ingram Professor in Biomedical Engineering, and her lab since 2018, recently received nearly $3 million from the National Institutes of Health to advance toward clinical studies, the university reported.

The research focuses specifically on the Jones fracture, a break in the fifth metatarsal—the long bone on the outside of the foot connected to the pinkie toe. Restoring blood flow is critical for bone healing, and this particular bone sits in what Choe described as a "sweet spot" where blood vessels often fail to supply enough blood for proper recovery.

"The bone is right in a sweet spot where the blood vessels often don't provide enough blood supply to properly heal the foot," Choe said in the university's announcement. "But it's hard to predict—sometimes it heals well and sometimes it doesn't. We want to use non-invasive imaging to clear up that gray area."

Choe's method combines two related techniques: diffuse optical tomography and diffuse correlation tomography. Near-infrared light, which sits just beyond visible red light on the electromagnetic spectrum, is directed at the injured foot in small beams covering a few inches. The light penetrates beneath the skin, allowing researchers to gather data on blood volume, oxygen content, and blood flow rate.

"That information can tell us whether blood flow is restored after the bone fracture," Choe said. "And since we're using light, it is safe to make frequent measurements to see how well revascularization is progressing."

Choe and her students have built a prototype device they plan to refine and begin testing on patients with Jones fractures, working with clinical collaborators at the University of Rochester Medical Center. The researchers envision the technique going beyond simple monitoring. They aim to predict how well a bone will heal, accounting for differences such as a patient's age and gender. When healing is not progressing as expected, they also want to use the technology to optimize the dosage and timing of treatments like parathyroid hormone therapy, which is already used for osteoporosis but not yet standard for fractures.

"Some researchers have tried using parathyroid hormone for fracture healing, but there is some discrepancy between dosage, timing, and other factors that need to be resolved for it to be applicable," Choe said. "We think our method can help optimize treatments being tested for fractures that do not heal well."

The study is expected to be completed in 2031, according to the university.